ADIPOQ and obesity disorder: Recently, our group has shown that adiponectin - a cytokine with marked anti-inflammatory, anti-atherogenic and insulin-sensitizing properties [13], inhibits spontaneous as well as catecholamine-induced lipolysis in non-obese subjects, while this effect was lost in obesity [14].